|
πΊπΈ FDA updates 'estimated duration' dates on Recommended Interim AI limits
|
|
1
|
255
|
August 3, 2026
|
|
N-Nitroso Perindopril Limit as NMI or 1500ng/day
|
|
3
|
279
|
May 21, 2026
|
|
N-Nitrosamine drug substance related impurities (NDSRIs) β A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da -Pub
|
|
0
|
375
|
October 28, 2024
|
|
π© CPCA Calculation Tool (excel-based) -Updated
|
|
85
|
13406
|
September 27, 2024
|
|
πΊπΈ FDA - Updated information on recommended AI for NDSRIs (23/Feb/2024) - Tables 2 & 3
|
|
16
|
4730
|
July 28, 2024
|
|
CPCA Calculation System (Python Desktop)
|
|
1
|
1677
|
November 22, 2023
|
|
AI for NDSRIs with positive EAT and/or in-vivo mutagenicity study - FDA position?
|
|
2
|
749
|
November 9, 2023
|